INBS ▲ +1.2% - Intelligent Bio Solutions Inc. $INBS - Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission Intelligent Bio Solutions rose 1.2% after announcing that its technology achieved above 98% accuracy in a method comparison study, a result the company said supports its planned 2026 FDA 510(k) submission. The high accuracy rate suggests the company's diagnostic approach meets performance benchmarks needed for regulatory clearance, potentially de-risking the FDA approval pathway. 01-SEP-2026 08:31 AM ET